Literature DB >> 681757

Human antibodies to immunoglobulin A (IgA). A radioimmunological method for differentiation between anti-IgA antibodies and IgA in the serum of IgA deficient individuals.

P J Van Munster, J H Nadorp, H J Schuurman.   

Abstract

In the sera of 12 out of 27 individuals with IgA deficiency (serum level below 0.02 mg IgA/ml) class-specific anti-IgA antibodies were demonstrated by haemagglutination. These sera showed false-positive results in a solid-phase inhibition radioimmunoassay (RIST) (apparent IgA concentration between 0.6 and 13.7 microgram IgA/ml) indicating that the RIST is not an appropriate test for the analysis of serum of IgA deficient individuals. A modification of the RIST is proposed (titration RIA) that permits differentiation between low levels of IgA and class-specific anti-IgA antibodies. With this test IgA deficient individuals could be classified as those with low but detectable levels of IgA and those with class-specific anti-IgA antibodies. A computer procedure was developed to calculate both the amount and the avidity (K) of the anti-IgA antibodies and to simulate the assay system. The K value calculated from experimental points proved to be an overestimation of the K value which fitted most adequately in the simulation. The comparison of the results with clinical findings indicated a possible correlation between the amount and the avidity of the anti-IgA antibodies and the appearance of anaphylactic reactions after transfusion of IgA.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 681757     DOI: 10.1016/0022-1759(78)90031-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Immunoglobulin A concentrations in commercial immune globulins.

Authors:  R Apfelzweig; D Piszkiewicz; J A Hooper
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

2.  Immunological investigations in individuals with selective IgA deficiency.

Authors:  T A Out; P J van Munster; P A De Graeff; T H Thé; J M Vossen; B J Zegers
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

3.  Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies.

Authors:  J Björkander; L Hammarström; C I Smith; R H Buckley; C Cunningham-Rundles; L A Hanson
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.